| The American College of Cardiology opinion on Vytorin as stated on their web site is "that major clinical decisions not be made on the basis of the ENHANCE study alone. This study deserves serious thought and follow-up. The overall incidence rates of cardiac events were nearly identical in both treatment groups, and both medicines were generally well tolerated. There should no be reason for patients to panic." Do you agree with the American College of Cardiology stand on Vytorin? | ||
|---|---|---|
| # | Response Date | Other (please specify) |
| 1. | 1/31/2008 4:51:00 PM | But as soon as Zetia/Vytorin were released they should have started a clinical outcome trial. They were a little late off the mark on that....but that probably protected their profits. |